News ArticleMore News »
Novum’s Scientific Leadership Presented at the EUFEPS/AAPS Second International Conference
Aug 29, 2016
Pittsburgh, PA: Leaders of Novum’s Scientific Affairs team – Keith Gallicano, Ph.D., VP, Scientific Affairs; Pina D’Angelo, MSc, Senior Director, Scientific Affairs (Biostatistics) – were Presenters on Day Two of the EUFEPS/AAPS International Conference Pina will present during the Global Bioequivalence Harmonization Initiative on Friday, September 16th at 11:30 a.m. She presented on the topic “Testing for Bioequivalence in Higher-Order Crossover Designs: Two-at-a-Time Principle Versus Pooled ANOVA”. Later that same day, at 2:45 p.m., Dr. Gallicano presented on the topic “Potential Reasons for Exceptional Product Performance (“Outlier Profiles”) in BE Studies”.
For over 40 years, Novum has been considered one of the world’s leaders in the conduct of clinical trials; Early Phase Research from First in Human studies to large bioequivalence studies are conducted at Clinical Pharmacology units in Houston, Texas; Las Vegas, Nevada; and Fargo, North Dakota. A separate division, managing Late Phase Research requiring patient populations across multiple therapeutic areas, is lead by the Clinical Trials Division headquartered in Pittsburgh, Pennsylvania.